174) Metacognitive training for patients with schizophrenia (MCT) is a nov |
175) s and found white matter abnormalities in patients with schizophrenia as compared wi |
176) conviction and other positive symptoms in patients with schizophrenia. |
177) FR; C677T) mutation was determined in 180 patients with sickle cell (SS) disease (12 |
178) cal abnormalities: healthy subjects (AA), patients with sickle cell SC disease (SC) |
179) n this study: 6 healthy subjects (AA), 11 patients with sickle cell-hemoglobin C dis |
180) f the pharmacologic therapies utilized in patients with symptomatic disease, only an |
181) t is significantly greater than normal in patients with symptomatic knee OA. |
182) his review will outline the management of patients with symptomatic systolic heart f |
183) ny reports of neurological involvement in patients with the craniofacial linear loca |
184) Seven patients with the following indications ha |
185) Thirty-one treated patients with the following indications we |
186) ed the characteristics and outcomes of 49 patients with AHA diagnosed in our center |
187) ive and safe to control acute bleeding in patients with AHA. |
188) and during anakinra administration among patients with BD were evaluated. |
189) Thirteen patients with BD were treated with session |
190) A convenient sample of 153 patients with CAD was recruited from the c |
191) port and selected sociodemographics among patients with CAD. |
192) inary NGAL as a predictor of CV events in patients with CKD. |
193) ies for arterial stiffness attenuation in patients with CKD. |
194) e that the decreased vitD levels, seen in patients with CVD and chronic immunopathol |
195) ascular and systemic inflammation seen in patients with CVD. |
196) IgG in old age or low antithrombin level patients with DIC with old age or low anti |
197) automated chemiluminescence system in 118 patients with DIC. |
198) revalence and clinical characteristics of patients with LGV since 2007 when active c |
199) Medical records of all patients with LGV were reviewed. |
200) The subjects were patients with MFS (n = 40) who attended th |
201) While it is known that patients with MFS are at high risk of dent |
202) , and medication use in a large cohort of patients with NE. |
203) We identified 115 patients with NE. |
204) We classified 355 patients with NSTE-ACS according to the ad |
205) s not associated with adverse outcomes in patients with NSTE-ACS treated with dual a |
206) heterozygous state was present in only 3 patients with SS disease and was absent in |
add keyword